{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:11:43Z","timestamp":1767960703235,"version":"3.49.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2882,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry & Biology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.chembiol.2005.09.005","type":"journal-article","created":{"date-parts":[[2005,10,24]],"date-time":"2005-10-24T14:13:05Z","timestamp":1130163185000},"page":"1063-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Chemical Genetics and Orphan Genetic Diseases"],"prefix":"10.1016","volume":"12","author":[{"given":"Mitchell R.","family":"Lunn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent R.","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2005.09.005_bib1","unstructured":"Orphan Drug Act. (1983). Public Law 97-414, as amended. U.S. Code 21, \u00a7 360ee."},{"key":"10.1016\/j.chembiol.2005.09.005_bib2","unstructured":"Rare Diseases Act. (2002). Public Law 107\u2013280. U.S. Code 21, \u00a7 360aa\u2013ee."},{"key":"10.1016\/j.chembiol.2005.09.005_bib3","unstructured":"McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University, and NCBI (2000). OMIM: Online Mendelian Inheritance in Man (http:\/\/www.ncbi.nlm.nih.gov\/omim\/)."},{"key":"10.1016\/j.chembiol.2005.09.005_bib4","first-page":"61","article-title":"Friedrich Wilhelm Sert\u00fcrner and the discovery of morphine","volume":"27","author":"Schmitz","year":"1985","journal-title":"Pharm. Hist."},{"key":"10.1016\/j.chembiol.2005.09.005_bib5","first-page":"445","article-title":"Chemotherapeutics: scientific principles, methods and results","volume":"2","author":"Ehrlich","year":"1913","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2005.09.005_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S0269889700000879","article-title":"Science as receptor of technology: Paul Ehrlich and the synthetic dyestuffs industry","volume":"3","author":"Travis","year":"1989","journal-title":"Sci. Context"},{"key":"10.1016\/j.chembiol.2005.09.005_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/171737a0","article-title":"Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid","volume":"171","author":"Watson","year":"1953","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1126\/science.139.3554.461","article-title":"On the genetic code","volume":"139","author":"Crick","year":"1963","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/1921227a0","article-title":"General nature of the genetic code for proteins","volume":"192","author":"Crick","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/2261209a0","article-title":"RNA-dependent DNA polymerase in virions of RNA tumour viruses","volume":"226","author":"Baltimore","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/2261211a0","article-title":"RNA-dependent DNA polymerase in virions of Rous sarcoma virus","volume":"226","author":"Temin","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib12","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1073\/pnas.70.11.3240","article-title":"Construction of biologically functional bacterial plasmids in vitro","volume":"70","author":"Cohen","year":"1973","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.005_bib13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.2999980","article-title":"Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia","volume":"230","author":"Saiki","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ng0492-3","article-title":"Positional cloning: let's not call it reverse anymore","volume":"1","author":"Collins","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng0495-347","article-title":"Positional cloning moves from perditional to traditional","volume":"9","author":"Collins","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/322032a0","article-title":"Cloning the gene for an inherited human disorder\u2013chronic granulomatous disease\u2013on the basis of its chromosomal location","volume":"322","author":"Royer-Pokora","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib17","first-page":"1034","article-title":"Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage","volume":"48","author":"Pericak-Vance","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib18","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.005_bib19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"International Human Genome Sequencing Consortium","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/35038557","article-title":"Chemical genetics: ligand-based discovery of gene function","volume":"1","author":"Stockwell","year":"2000","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature03196","article-title":"Exploring biology with small organic molecules","volume":"432","author":"Stockwell","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib22","first-page":"51","article-title":"The small-molecule approach to biology: chemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology","volume":"81","author":"Schreiber","year":"2003","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.chembiol.2005.09.005_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.chembiol.2005.09.005_bib24","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.005_bib25","doi-asserted-by":"crossref","first-page":"29148","DOI":"10.1074\/jbc.M100898200","article-title":"A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1 alpha,25-dihydroxyvitamin D(3)","volume":"276","author":"Gardezi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2005.09.005_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-3011.1991.tb00765.x","article-title":"General method for rapid synthesis of multicomponent peptide mixtures","volume":"37","author":"Furka","year":"1991","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.chembiol.2005.09.005_bib27","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1126\/science.287.5460.1964","article-title":"Target-oriented and diversity-oriented organic synthesis in drug discovery","volume":"287","author":"Schreiber","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib28","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1021\/ja981746o","article-title":"Stereoselective synthesis of over two million compounds having structural features both reminiscent of natural products and compatible with miniaturized cell-based assays","volume":"120","author":"Tan","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2005.09.005_bib29","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1021\/ol048273c","article-title":"Syntheses of stereochemically diverse nine-membered ring-containing biaryls","volume":"6","author":"Krishnan","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.chembiol.2005.09.005_bib30","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1073\/pnas.0404425101","article-title":"Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens","volume":"101","author":"Bailey","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.005_bib31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.chembiol.2004.08.026","article-title":"A flexible data analysis tool for chemical genetic screens","volume":"11","author":"Kelley","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1087057103254282","article-title":"Detecting spatial patterns in biological array experiments","volume":"8","author":"Root","year":"2003","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.chembiol.2005.09.005_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chembiol.2005.01.006","article-title":"The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus","volume":"12","author":"Tanner","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib34","first-page":"2141","article-title":"Identification of novel mdm2 binding peptides by phage display","volume":"13","author":"Bottger","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2005.09.005_bib35","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1126\/science.285.5428.744","article-title":"Peptide antagonists of the human estrogen receptor","volume":"285","author":"Norris","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.chembiol.2005.02.007","article-title":"Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2","volume":"12","author":"Choi","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib37","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.chembiol.2004.08.006","article-title":"Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII","volume":"11","author":"Spiegel","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib38","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.chembiol.2004.09.011","article-title":"High-affinity small molecule inhibitors of T cell costimulation: compounds for immunotherapy","volume":"11","author":"Huxley","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-5521(99)80004-0","article-title":"High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications","volume":"6","author":"Stockwell","year":"1999","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib40","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1021\/ja9921221","article-title":"Chemical genetic and genomic approaches reveal a role for copper in specific gene activation","volume":"121","author":"Stockwell","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2005.09.005_bib41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chembiol.2005.02.014","article-title":"Dissection of melanogenesis with small molecules identifies prohibitin as a regulator","volume":"12","author":"Snyder","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.chembiol.2005.01.015","article-title":"Screening for cell migration inhibitors via automated microscopy reveals a rho-kinase inhibitor","volume":"12","author":"Yarrow","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib43","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0960-894X(99)00122-5","article-title":"4-Phenylthiazole derivatives inhibit IL-6 secretion in osteoblastic cells and suppress bone weight loss in ovariectomized mice","volume":"9","author":"Yamaguchi","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2005.09.005_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-5521(00)00101-0","article-title":"Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis","volume":"7","author":"Haggarty","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2005.09.005_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2005.09.005_bib47","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.272.5260.408","article-title":"A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p","volume":"272","author":"Taunton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(91)90004-6","article-title":"Effects of antimitotic agents on tubulin-nucleotide interactions","volume":"52","author":"Correia","year":"1991","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2005.09.005_bib49","first-page":"593","article-title":"Target identification in chemical genetics: the (often) missing link","volume":"11","author":"Burdine","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib50","first-page":"13404","article-title":"Bivalent inhibitors of protein tyrosine kinases","volume":"125","author":"Profit","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2005.09.005_bib51","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1073\/pnas.97.6.2419","article-title":"Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors","volume":"97","author":"Maly","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.005_bib52","doi-asserted-by":"crossref","first-page":"13995","DOI":"10.1021\/ja036417x","article-title":"Isolation of protein ligands from large peptoid libraries","volume":"125","author":"Alluri","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2005.09.005_bib53","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1073\/pnas.0732087100","article-title":"Synthetic small molecules that control stem cell fate","volume":"100","author":"Ding","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.005_bib54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/13690","article-title":"Quantitative analysis of complex protein mixtures using isotope-coded affinity tags","volume":"17","author":"Gygi","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0167-7799(99)01402-X","article-title":"Using photolabile ligands in drug discovery and development","volume":"18","author":"Dorman","year":"2000","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib56","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.7910982","article-title":"De novo and inherited deletions of the 5q13 region in spinal muscular atrophies","volume":"264","author":"Melki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib57","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","article-title":"Classification of spinal muscular atrophies","volume":"1","author":"Pearn","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2005.09.005_bib58","first-page":"1052","article-title":"Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy","volume":"24","author":"Al-Jumah","year":"2003","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.chembiol.2005.09.005_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0896-6273(02)01056-5","article-title":"Chemical genetic screening approaches to neurobiology","volume":"36","author":"Stockwell","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2005.09.005_bib60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/geno.1996.0147","article-title":"Structure and organization of the human survival motor neurone (SMN) gene","volume":"32","author":"Burglen","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.chembiol.2005.09.005_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2005.09.005_bib62","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1126\/science.1090100","article-title":"Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays","volume":"302","author":"Johnson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/418236a","article-title":"Alternative pre-mRNA splicing and proteome expansion in metazoans","volume":"418","author":"Maniatis","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib64","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/brain\/awg090","article-title":"Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia","volume":"126","author":"Stanford","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.chembiol.2005.09.005_bib65","first-page":"535","article-title":"A novel mutation at position +11 in the intron following exon 10 of the tau gene in FTDP-17","volume":"43","author":"Kowalska","year":"2002","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/rr82","article-title":"\u2018CFTR-opathies\u2019: disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations","volume":"2","author":"Noone","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.chembiol.2005.09.005_bib67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000472312","article-title":"Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens","volume":"3","author":"Costes","year":"1995","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib68","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.005_bib69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib70","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","author":"Kashima","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib71","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"Coovert","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nsb887","article-title":"Correction of disease-associated exon skipping by synthetic exon-specific activators","volume":"10","author":"Cartegni","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1101\/gr.7.4.339","article-title":"Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene","volume":"7","author":"DiDonato","year":"1997","journal-title":"Genome Res."},{"key":"10.1016\/j.chembiol.2005.09.005_bib75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-1119(97)00510-6","article-title":"Identification and characterization of a mouse homologue of the spinal muscular atrophy-determining gene, survival motor neuron","volume":"204","author":"Bergin","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.chembiol.2005.09.005_bib76","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos","volume":"94","author":"Schrank","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chembiol.2005.09.005_bib77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib79","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany)","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.chembiol.2005.09.005_bib80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0022-510X(78)90072-2","article-title":"Autosomal dominant spinal muscular atrophy: a clinical and genetic study","volume":"38","author":"Pearn","year":"1978","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.chembiol.2005.09.005_bib81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/brain\/101.4.591","article-title":"A clinical and genetic study of spinal muscular atrophy of adult onset: the autosomal recessive form as a discrete disease entity","volume":"101","author":"Pearn","year":"1978","journal-title":"Brain"},{"key":"10.1016\/j.chembiol.2005.09.005_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1034\/j.1600-0404.2003.00181.x","article-title":"Gene conversion events in adult-onset spinal muscular atrophy","volume":"109","author":"Mazzei","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.chembiol.2005.09.005_bib83","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(95)91507-9","article-title":"Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy","volume":"346","author":"Brahe","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2005.09.005_bib84","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(95)92881-2","article-title":"SMN gene deletions in adult-onset spinal muscular atrophy","volume":"346","author":"Clermont","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2005.09.005_bib85","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/513913","article-title":"When is a deletion not a deletion? When it is converted","volume":"61","author":"Burghes","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib87","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"McAndrew","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib88","first-page":"834","article-title":"Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5","volume":"59","author":"van der Steege","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/1753","article-title":"Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics","volume":"20","author":"Scharf","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib90","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/hmg\/6.11.1961","article-title":"Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system","volume":"6","author":"Battaglia","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib91","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1126\/science.1074962","article-title":"Essential role for the SMN complex in the specificity of snRNP assembly","volume":"298","author":"Pellizzoni","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2005.09.005_bib92","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1093\/emboj\/cdf585","article-title":"Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs","volume":"21","author":"Meister","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2005.09.005_bib93","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200303168","article-title":"Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding","volume":"162","author":"McWhorter","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib94","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons","volume":"163","author":"Rossoll","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib95","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.1074\/jbc.M308225200","article-title":"Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene","volume":"279","author":"Majumder","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2005.09.005_bib96","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.20548","article-title":"Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells","volume":"58","author":"Grzeschik","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib97","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib98","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib99","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chembiol.2005.09.005_bib100","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.neuint.2004.04.005","article-title":"Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin\/proteasome pathway","volume":"45","author":"Chang","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.chembiol.2005.09.005_bib101","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddi131","article-title":"A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels","volume":"14","author":"Wolstencroft","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib102","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","article-title":"Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients","volume":"10","author":"Andreassi","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib103","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.chembiol.2004.08.024","article-title":"Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism","volume":"11","author":"Lunn","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib104","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.chembiol.2003.08.009","article-title":"Biological mechanism profiling using an annotated compound library","volume":"10","author":"Root","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib105","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/hmg\/ddi205","article-title":"Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy","volume":"14","author":"Jarecki","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.005_bib107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.chembiol.2005.09.005_bib108","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.60.11.1601","article-title":"A phase 1 trial of riluzole in spinal muscular atrophy","volume":"60","author":"Russman","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib109","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1074\/jbc.M009162200","article-title":"A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2005.09.005_bib110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1020155510718","article-title":"A review of protein-small molecule docking methods","volume":"16","author":"Taylor","year":"2002","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.chembiol.2005.09.005_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1359-6446(04)02939-3","article-title":"Novel technologies for virtual screening","volume":"9","author":"Lengauer","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2005.09.005_bib112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1359-6446(01)02091-8","article-title":"Virtual screening and fast automated docking methods","volume":"7","author":"Schneider","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2005.09.005_bib113","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2004.11.015","article-title":"A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy","volume":"338","author":"Chen","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chembiol.2005.09.005_bib114","first-page":"1270","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2005.09.005_bib115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1074-5521(03)00093-0","article-title":"Chemical genetic modifier screens. Small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation","volume":"10","author":"Koeller","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib116","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nchembio0705-64","article-title":"Small molecules: the missing link in the central dogma","volume":"1","author":"Schreiber","year":"2005","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.chembiol.2005.09.005_bib117","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nbt961","article-title":"Encoded self-assembling chemical libraries","volume":"22","author":"Melkko","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2005.09.005_bib118","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1073\/pnas.1337088100","article-title":"Systematic discovery of multicomponent therapeutics","volume":"100","author":"Borisy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chembiol.2005.09.005_bib119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2005.09.005_bib120","doi-asserted-by":"crossref","first-page":"14740","DOI":"10.1021\/ja048170p","article-title":"Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space","volume":"126","author":"Kim","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2005.09.005_bib121","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature02870","article-title":"Unlocking the potential of the human genome with RNA interference","volume":"431","author":"Hannon","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib122","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","article-title":"Mechanisms of gene silencing by double-stranded RNA","volume":"431","author":"Meister","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib123","first-page":"725","article-title":"To affinity and beyond","volume":"426","author":"Moore","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2005.09.005_bib124","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng1305","article-title":"Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation","volume":"36","author":"Stegmaier","year":"2004","journal-title":"Nat. Genet."}],"container-title":["Chemistry & Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552105002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552105002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:06:08Z","timestamp":1761030368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074552105002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":124,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1074552105002942"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2005.09.005","relation":{},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical Genetics and Orphan Genetic Diseases","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2005.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}